Effects of Continuity of Care on Medication Duplication Among the Elderly

Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taipei, Taiwan.
Medical care (Impact Factor: 3.23). 12/2013; 52(2). DOI: 10.1097/MLR.0000000000000042
Source: PubMed


The effects of continuity of care on health care outcomes are well documented. However, little is known about the effect of continuity at the physician or the site level on the process of care for patients with multiple chronic conditions (MCCs).
The objective of this study was to examine the effects of physician continuity versus site continuity on duplicated medications received by patients with and without MCCs.
This study utilized a longitudinal design with an 8-year follow-up from 2004 to 2011 of patients aged 65 or older under a universal health insurance program in Taiwan (55,573 subjects and 389,011 subject-years). Generalized estimating equation models with propensity score method were conducted to assess the association between continuity and medication duplication.
The rates of subjects receiving duplicated medications ranged from 40.38% to 43.50% with 1.45-1.62 duplicated medications during the study period. The findings revealed that better continuity, either at the physician level or the site level, was significantly associated with fewer duplicated medications. This study also indicated that the physician continuity had a stronger effect on medication duplication than did site continuity. Furthermore, the magnitude of the protective effect of continuity against duplicated medications increased when the patients had more chronic conditions [physician continuity: the marginal effect ranged from -10.7% to -52.9% (all P<0.001); site continuity: the marginal effect ranged from -0.4% (P=0.063) to -31.4% (P<0.001)].
Improving either physician continuity or site continuity may result in fewer duplicated medications, particularly for patients with MCCs.

9 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patient-doctor continuity is valued by both parties, yet the effect of the depth of the patient-doctor relationship on the content of consultations in general practice is unknown. To assess whether differences in the depth of relationship between a patient and their GP affects the length of consultations, and the number and type of problems and issues raised during a consultation. Cross-sectional study in 22 GP practices in the UK. GP consultations (n = 229) were videotaped and the number of problems and aspects of those problems and issues identified. Patients completed the Patient-Doctor Depth of Relationship (PDDR) and General Practice Assessment Questionnaire-communication (GPAQc) scales. Associations were explored using multivariable linear and logistic regression. Complete data were available on 190 participants consulting 30 GPs. In unadjusted analysis, patients with a deep relationship with their GP discussed more problems (mean 2.8) and issues (mean 4.7) compared with those with a moderate (2.4 problems; 4.0 issues) or shallow (2.3 problems; 3.8 issues) relationship. Patients with deep relationships had consultations that were on average 118 seconds (95% CI = 1 to 236) longer than those with shallow relationships. Adjustment for participant and GP factors attenuated these relationships, although the main trends persisted. A greater number of problems and issues may be raised in a consultation when patients have a deeper relationship with their GP. Over several clinical encounters each year, this may be associated with significant benefits to patients and efficiencies in GP consultations and warrants further investigation. © British Journal of General Practice 2015.
    British Journal of General Practice 08/2015; 65(637):e545-51. DOI:10.3399/bjgp15X686125 · 2.29 Impact Factor